Everlab Raises US$10M Seed Round to Deliver Scalable, AI-Powered Preventive Healthcare

MELBOURNE, Australia–(BUSINESS WIRE)–Everlab, the AI-powered health platform reimagining preventive care, today announced a US$10 million (AU$15 million) seed round led by global growth equity firm Left Lane Capital. The funding will accelerate Everlab’s international expansion, fuel the development of its proprietary AI healthtech platform, and support the rollout of a deeply integrated product ecosystem designed … [Read more…]

Akumin Bolsters Leadership Team

Victoria Garcia Appointed Chief Financial Officer Paul Boothe Named President of Mobile & Oncology Alex Reynolds Appointed President of Fixed Radiology PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (“Akumin” or the “Company”), a leader in managed radiology and oncology services, today announced the appointment of Victoria Garcia as Chief Financial Officer, concluding the previously announced search for a … [Read more…]

Acute Pain Market Report 2025-2035, Competitive Analysis of Talphera, Medical Developments International, Vivozon, Formosa Pharmaceuticals, Teikoku Pharma, and Charleston Laboratories – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acute Pain Market – A Global and Regional Analysis: Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global acute pain market is experiencing several key emerging trends. One significant trend is the shift toward non-opioid pain management solutions. In response to the growing opioid crisis and the associated risks … [Read more…]

Wet Age-Related Macular Degeneration (Wet AMD) Market Analysis and Forecasts 2025-2035 with Regeneron Pharmaceuticals, Kubota Pharmaceutical, and Adverum Biotechnologies Leading – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wet Age-Related Macular Degeneration (Wet AMD) Market – A Global and Regional Analysis: Focus on Treatment Type, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global wet age-related macular degeneration market is experiencing robust growth, driven by an aging population, increasing awareness about the condition, and … [Read more…]

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

Longer-term follow up in the FLAURA2 Phase III trial confirms the favorable benefit-risk profile of this combination Overall survival results reinforce TAGRISSO as the backbone therapy in EGFRm lung cancer across stages WILMINGTON, Del.–(BUSINESS WIRE)–Positive high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) with … [Read more…]

500 Global Taps UN SDG Architect, Dr. Alaa Murabit, to Launch Firm’s New Offerings in Sustainable Growth

Dr. Alaa Murabit, TIME100 honoree, Gates Foundation Alum, and global security leader, will lead 500 Global’s Sustainable Growth practice in emerging markets, advancing the firm’s commitment to increase blended finance and public-private investment models that unlock innovation and inclusive economic development. SAN FRANCISCO–(BUSINESS WIRE)–500 Global, one of the world’s most active venture capital firms1, today … [Read more…]

Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula

Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and patient-reported symptoms with excellent safety profile IRVINE, Calif.–(BUSINESS WIRE)–#clinicaltrials–Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evaluating CBT-004 ophthalmic solution in patients with vascularized … [Read more…]

Sarepta Therapeutics Provides Statement on ELEVIDYS

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of ELEVIDYS (delandistrogene moxeparvovec), our gene therapy for Duchenne muscular dystrophy (Duchenne), … [Read more…]

Prime Healthcare Services, Inc. Schedules 2025 2nd Quarter Earnings Conference Call

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of August 12th, 2025, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. … [Read more…]

73% of Rural Healthcare Orgs Say They Struggle to Maintain HIPAA Compliance Due to Staffing and Funding Gaps

Paubox survey reveals rural providers are struggling with every major challenge—from staffing to infrastructure—as cyber threats rise SAN FRANCISCO–(BUSINESS WIRE)–#emailsecurity–As cyber threats grow more frequent and sophisticated, rural hospitals and clinics face challenges on all fronts—tight budgets, limited staff, inadequate training, complex technology, and unsupportive vendors. Many are left trying to manage security tools without … [Read more…]